Explore our comprehensive coverage of muscle loss, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The widespread adoption of GLP-1 agonists has triggered an unprecedented surge in sarcopenia among fitness demographics. This analysis dissects the ma...
Read Full Story →
Nutrition & FitnessGLP-1 medications have reached 21% of U.S. households while causing 15-40% lean muscle mass loss and...
Nutrition & FitnessA landmark narrative review published July 3, 2026, in The Journal of Nutrition outlines critical di...
